Universitatsklinikum Jena Klinik Fur Innere Medizin Ii

Jena 07747

2 studies enrolling now · 2 studies all time

What they study most

B-cell Lymphoma, B-cell Malignancy, Chronic Lymphocytic Leukemia, Refractory Cancer, Relapsed Cancer, Small Lymphocytic Lymphoma

Studies at this site

• A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) — Recruiting now
• A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies — Recruiting now